Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bendamustine vs Chlorambucil in Untreated CLL
NCT01657955Phase 3Unknown
- Sponsor
- Shandong Lanjin Pharmaceuticals
- Start
- Jan 2011
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bendamustine in chronic lymphocytic leukemia (CLL), sponsored by Shandong Lanjin Pharmaceuticals. Status: unknown.
02
Drugs
bendamustine
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT01657955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01657955.